Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00870311 · ClinicalTrials.gov registry record · Phase 4
Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients
A Phase 4 study, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00870311 is a Phase 4 study that has completed, run by Wayne State University. The registered enrollment target is 28 participants.
The verdict
NCT00870311, a Phase 4 study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study investigates the effects of Lithium treatment on signal transduction pathways, gene expression and brain neurochemistry and structure in patients with Bipolar disorder. It is hypothesized that specific changes in these markers will correlate with lithium treatment responsiveness.
Interventions
- DRUG Lithium Carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 1996-03 |
| Est. Completion | 2004-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00870311
The ClinicalTrials.gov registry entry for NCT00870311 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lithium Carbonate is the first listed.
NCT00870311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00870311 about?
NCT00870311 is a clinical study titled "Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients". This study investigates the effects of Lithium treatment on signal transduction pathways, gene expression and brain neurochemistry and structure in patients with Bipolar disorder. It is hypothesized that specific changes in these markers will correlate with lithium treatment responsiveness.
What is the current status of trial NCT00870311?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 1996-03. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00870311?
The interventions under investigation include: Lithium Carbonate (DRUG).
Who is sponsoring clinical trial NCT00870311?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.